➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Mallinckrodt
Johnson and Johnson
AstraZeneca
Medtronic

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Calcium gluconate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for calcium gluconate and what is the scope of patent protection?

Calcium gluconate is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa and Hq Spclt Pharma, and is included in two NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are two hundred and eighty-two drug master file entries for calcium gluconate. Five suppliers are listed for this compound.

Drug Prices for calcium gluconate

See drug prices for calcium gluconate

Recent Clinical Trials for calcium gluconate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Medical Universtity of LodzPhase 4
University of MalayaPhase 4
Woman'sPhase 4

See all calcium gluconate clinical trials

Pharmacology for calcium gluconate

US Patents and Regulatory Information for calcium gluconate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa CALCIUM GLUCONATE calcium gluconate SOLUTION;INTRAVENOUS 208418-002 Jun 15, 2017 RX Yes Yes   Start Trial   Start Trial   Start Trial
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-002 Oct 29, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-002 Oct 29, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Fresenius Kabi Usa CALCIUM GLUCONATE calcium gluconate SOLUTION;INTRAVENOUS 208418-001 Jun 15, 2017 RX Yes Yes   Start Trial   Start Trial   Start Trial
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-001 Oct 29, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-001 Oct 29, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Medtronic
Harvard Business School
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.